logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (vii) All inpatient clients, age distribution by primary drug (%)

Substance<1515-1920-2425-2930-3435-3940-4445+Mean ageAge knownAge not known
Hypnotics and sedatives0.13.410.514.813.49.912.035.939.8153815
Volatile substances4.743.616.417.310.
Cannabis 0.817.430.821.812.
Other substances 0.26.726.424.


 The countries supplying data are: 

 AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK.   

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page


 Reitox national reports 2010 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011